We are live on
!
Find out more
AIM
Alerce Investment Management Portfolio holdings
AUM
$56.8M
1-Year Est. Return
31.17%
This Fund
S&P 500
This Quarter
Est. Return
-17.03%
1 Year Est. Return
+31.17%
3 Year Est. Return
+25.12%
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$254M
AUM Growth
–
Cap. Flow
+$292M
Cap. Flow
% of AUM
114.93%
Top 10 Holdings %
Top 10 Hldgs %
100%
Holding
7
New
7
Increased
–
Reduced
–
Closed
–
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
American Well
AMWL
|
+$182M |
| 2 |
Annexon
ANNX
|
+$50.3M |
| 3 |
Assembly Biosciences
ASMB
|
+$21.8M |
| 4 |
Akebia Therapeutics
AKBA
|
+$13.6M |
| 5 |
RNTX
Rein Therapeutics
RNTX
|
+$9.51M |
Top Sells
No sells this quarter
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 100% |
Similar funds
CCP
AFA
MCC
SGL
MC
OAM
IP
JCP
Alerce Investment Management's Q4 2020 Portfolio in Review
Q4 2020 is the first quarter with a 13F filing on record for Alerce Investment Management, which disclosed 7 positions worth $254M. Its ten largest holdings account for 100% of the portfolio.
Its largest position is American Well: 315,039 shares worth $160M.
By sector, the portfolio is most concentrated in Healthcare at 100% of assets.
- Alerce Investment Management's largest Q4 2020 buy was American Well: 315,039 shares worth $160M.
- Alerce Investment Management's ten largest holdings make up 100% of its $254M portfolio in Q4 2020.
- Alerce Investment Management disclosed 7 positions in Q4 2020, its first 13F filing on record.
Based on Alerce Investment Management's 13F filing for Q4 2020, filed 11 Feb 2021.